EyePoint Pharmaceuticals, Inc. (EYPT) Social Stream



EyePoint Pharmaceuticals, Inc. (EYPT): $3.33

-0.06 (-1.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

EYEPOINT PHARMACEUTICALS INC (EYPT) Price Targets From Analysts

Use the tables below to see what analysts covering EYEPOINT PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 3 $25 $15 $20.666 $3.2 545.81%
2021-11-15 3 $35 $15 $27 $3.2 743.75%
2022-02-14 2 $35 $24 $30 $3.2 837.5%
2022-06-22 3 $35 $24 $30 $3.2 837.5%
2022-08-02 4 $35 $21 $27.75 $3.2 767.19%
2022-11-03 4 $35 $21 $28 $3.2 775%
2022-11-11 5 $52 $21 $32.8 $3.2 925%

The Trend in the Analyst Price Target


EYPT's average price target has moved up $13.72 over the prior 17 months.

Over the past 39 weeks, EYPT's average upside potential has been 266.45%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-04 3 35 24 30.00 11.44 162.24%
2022-05-05 3 35 24 30.00 11.30 165.49%
2022-07-18 4 35 21 27.75 9.79 183.45%
2022-08-04 4 35 21 28.00 10.51 166.41%
2022-11-11 5 52 21 32.80 4.63 608.42%

EYPT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


EYPT's average broker recommendation rating improved by 0 over the prior 35 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • EYEPOINT PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 664.99% of all US stocks.
  • EYEPOINT PHARMACEUTICALS INC's number of analysts covering the stock is greater than 90.63% of all US stocks.
  • EYEPOINT PHARMACEUTICALS INC's average analyst price target is greater than 141.81% of Measuring and Control Equipment stocks.
  • In the context of Measuring and Control Equipment stocks, EYEPOINT PHARMACEUTICALS INC's variance in analysts' estimates is lower than -384.26% of them.

In the Measuring and Control Equipment industry, AXDX, DNAY, and RPID are the three stocks most similar to EYEPOINT PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for EYPT? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6625 seconds.